An AI tool that can analyze abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukemia are ...
Long COVID patients show significantly higher levels of 'microclots,' abnormal clumps of blood-clotting proteins, as well as ...
CHICAGO (Reuters) - Older patients whose red blood cell counts are even slightly out of the normal range are at higher risk of death and heart problems after major surgery, U.S. researchers said on ...
The shape of sickle cell blood cells resembles a curved blade knife called a sickle. These cells are stiff and inflexible, so they cannot move through small blood vessels as easily as healthy red ...
A new AI system can analyse blood cell shapes with higher accuracy than human experts and detect abnormalities often ...
Researchers have developed a generative AI system called CytoDiffusion that can analyze blood cells with a level of precision that rivals, and in some cases exceeds, human experts.
An AI tool called CytoDiffusion can detect abnormal blood cells with greater accuracy and reliability than human specialists.
Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...
Findings expand Telomir-1’s oncology profile into cancers of the blood, adding to previously reported activity in triple-negative breast, pancreatic, and aggressive prostate cancer models. MIAMI, FL / ...
Lowering blood pressure and cholesterol levels, quitting smoking, managing diabetes: these evidence-backed approaches remain key ways to reduce the risk of cardiovascular disease (SN: 11/9/15). But an ...
Fresh blood was obtained from the previously described family W (23) and family G. (with two children with HLH) from the Immunobiology Unit, Institute for Child Health, London, UK. Peripheral blood ...
Researchers at the National Institutes of Health (NIH) found previously undetected cancers in 48.6% of pregnant people who had abnormal results for prenatal cell-free DNA (cfDNA) testing used to ...